February 23, 2023 Experience Mirion Technologies $150 million registered direct offering We advised Mirion on the offering
February 21, 2023 Experience CStone Pharmaceuticals HK$392.9 million placing of new shares We advised CStone Pharmaceuticals on the placement
February 21, 2023 Experience Sun Country Airlines $103.69 million secondary offering The shares are listed on the Nasdaq Global Select Market
February 14, 2023 Experience Pepkor Holdings ZAR 4.9 billion secondary offering The accelerated bookbuild transaction represented approximately 7.2% of Pepkor’s issued share capital
February 10, 2023 Experience CureVac $250 million follow-on offering We advised CureVac on the equity offering
February 10, 2023 Experience RxSight $50 million follow-on offering The stock is listed on the Nasdaq Global Market
February 10, 2023 Experience Xponential Fitness $122.5 million secondary offering We advised Xponential Fitness on the offering
February 7, 2023 Experience ADC Therapeutics secondary offering We advised ADC Therapeutics on the registered secondary offering of its shares
February 7, 2023 Experience Roivant Sciences $230 million stock offering We advised the company on its SEC-registered offering
January 30, 2023 Experience TD SYNNEX $502 million secondary offering The shares are listed on the NYSE